Company Profile

JILIN CHANGLONG

8049 Drug Manufacturers - Specialty & Generic
Description

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers Edaravone injection, compound brain comfort capsules, haikun kidney hi capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine glucosa tablets, prostate laurel yellow tablets, tranquility tablets, pharyngitis tablets, and low back pain capsules. The company markets its products under the Changlong and Qing Tong brands. It also engages in the manufacture and distribution of beverages and prepackaged food. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Reports

This company has 4 ESG reports available.

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
12 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Revenue) 3
Total GHG Emissions 3
Direct GHG Emissions (Scope 1) 3
Indirect Energy Emissions (Scope 2) 3

A2.1 Energy Consumption
22 Data Points
Indicator Data Points Actions
Energy Consumption Intensity (By Revenue) 3
Total Energy Consumption 3
Total Direct Energy Consumption 4
Total Non-Renewable Fuel Consumption 2
Fossil Fuel Consumption 1
Total Indirect Energy Consumption 4
Total Purchased Energy 1
Purchased Electricity 3
Grid Electricity Consumption 1
A2.2 Water Consumption
7 Data Points
Indicator Data Points Actions
Water Consumption 4
Water Consumption Intensity (By Revenue) 3
A2.5 Total Packaging Material Used
9 Data Points
Indicator Data Points Actions
Packaging Materials Consumed 3
Packaging Material Intensity (By Revenue) 3
Packaging Material Consumption (Paper) 3

B1.1 Amount and Distribution of Workforce
81 Data Points
Indicator Data Points Actions
Number of Total Employees 3
Number of Male Employees 3
Number of Female Employees 3
Percentage of Male Employees 3
Percentage of Female Employees 3
Number of Full-time Employees 3
Number of Part-time Employees 3
Percentage of Full-time Employees 3
Percentage of Part-time Employees 3
Number of Employees Aged Below 30 3
Number of Employees Aged 30-50 3
Number of Employees Aged Above 50 3
Percentage of Employees Aged Below 30 3
Percentage of Employees Aged 30-50 3
Percentage of Employees Aged Above 50 3
Number of Employees in Hong Kong 3
Number of Employees in Mainland China 3
Number of Employees in Hong Kong and Mainland China 3
Percentage of Employees in Hong Kong 3
Percentage of Employees in Mainland China 3
Percentage of Employees in Hong Kong and Mainland China 3
Number of Senior Management Employees 3
Number of Middle Management Employees 3
Number of General Employees 3
Percentage of Senior Management Employees 3
Percentage of Middle Management Employees 3
Percentage of General Employees 3
B1.2 Employee Turnover Rate
18 Data Points
Indicator Data Points Actions
Turnover Rate of Female Employees 3
Turnover Rate of Male Employees 3
Turnover Rate of Employees Aged Below 30 3
Turnover Rate of Employees Aged 30-50 3
Turnover Rate of Employees Aged Above 50 3
Turnover Rate of Employees in Mainland China 3

B3.1 The Percentage of Employees Trained
18 Data Points
Indicator Data Points Actions
Percentage of Employees Trained 3
Percentage of Trained Male Employees 3
Percentage of Trained Female Employees 3
Percentage of Trained Senior Management 3
Percentage of Trained Middle Management 3
Percentage of Trained General Employees 3
B3.2 Average Training Hours Completed per Employee
15 Data Points
Indicator Data Points Actions
Average Training Hours (Male) 3
Average Training Hours (Female) 3
Average Training Hours (Senior Management) 3
Average Training Hours (Middle Management) 3
Average Training Hours (General Employees) 3

ESG Reports